Prospect Capital Corporation
Prospect Capital Corporation (PBY) Financial Performance & Income Statement Overview
Analyze Prospect Capital Corporation (PBY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Prospect Capital Corporation (PBY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Prospect Capital Corporation PBY financial performance.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $148.60M | $151.47M | $71.95M | $132.45M |
Cost of Revenue | $0.00 | $0.00 | $58.62M | $56.61M |
Gross Profit | $148.60M | $151.47M | $13.32M | $75.84M |
Gross Profit Ratio | $1.00 | $1.00 | $0.19 | $0.57 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $4.42M | $4.81M | $10.95M | $11.39M |
Operating Expenses | $99.03M | $106.43M | $14.67M | -$108.43M |
Total Costs & Expenses | $99.03M | $106.43M | $2.59M | -$51.82M |
Interest Income | $168.80M | $184.62M | $189.30M | $183.93M |
Interest Expense | $33.21M | $35.23M | $36.08M | $36.33M |
Depreciation & Amortization | $0.00 | $0.00 | $437.39M | -$134.22M |
EBITDA | $0.00 | $0.00 | $69.36M | $0.00 |
EBITDA Ratio | $0.00 | $0.00 | $0.96 | $1.39 |
Operating Income | $49.56M | $45.04M | $69.36M | $184.27M |
Operating Income Ratio | $0.33 | $0.30 | $0.96 | $1.39 |
Other Income/Expenses (Net) | -$49.63M | -$179.05M | $383.52M | $10.14M |
Income Before Tax | -$66000.00 | -$134.01M | $29.56M | $144.36M |
Income Before Tax Ratio | -$0.00 | -$0.88 | $0.41 | $1.09 |
Income Tax Expense | $0.00 | $0.00 | -$293.84M | $134.22M |
Net Income | -$66000.00 | -$134.01M | $29.56M | $144.36M |
Net Income Ratio | -$0.00 | -$0.88 | $0.41 | $1.09 |
EPS | $0.21 | -$0.38 | $0.07 | $0.27 |
Diluted EPS | $0.21 | -$0.38 | $0.07 | $0.20 |
Weighted Avg Shares Outstanding | $436.69M | $428.87M | $424.85M | $414.46M |
Weighted Avg Shares Outstanding (Diluted) | $436.69M | $428.87M | $424.85M | $678.35M |
Over the past four quarters, Prospect Capital Corporation demonstrated steady revenue growth, increasing from $132.45M in Q3 2024 to $148.60M in Q2 2025. Operating income reached $49.56M in Q2 2025, maintaining a consistent 33% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to -$66000.00, with EPS at $0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan